Comment on Kanis et al.: "european guidance for the diagnosis and management of osteoporosis in postmenopausal women"

Osteoporosis International

Volumn 20, Issue 9, 2009, Pages 1631-

  Clausen, J O ^a  

^a Nycomed Denmark   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE; PARATHYROID HORMONE[1-34];

BIOEQUIVALENCE; DRUG BIOAVAILABILITY; EUROPE; LETTER; MOLECULAR WEIGHT; MOLECULE; POSTMENOPAUSE OSTEOPOROSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL;

BONE DENSITY CONSERVATION AGENTS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONE; TERIPARATIDE; THERAPEUTIC EQUIVALENCY;

EID: 68949206644     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-008-0812-y     Document Type: Letter

References (5)

1. J Kanis, et al 2008 European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporos Int 19 399 428
2. H Zhou, et al 2002 Solid phase synthesis of N terminal 1-34 peptide of human parathyroid hormone Zhongguo Shenghua Yaowu Zazhi 23 109 111
3. Y Ishibashi, et al 1993 Fragmentation of parathyroid hormone, a 9.4 kDa polypeptide, in liquid secondary ion mass spectrometry Biol Mass Spectrom 22 98 100
4. EPAR (2004) Forsteo scientific discussion. http://www.emea.europa.eu/ humandocs/PDFs/EPAR/forsteo/659802en6.pdf
5. EPAR (2006) Preotact scientific discussion. http://www.emea.europa.eu/ humandocs/PDFs/EPAR/preotact/H-659-en6.pdf